Clinical trial for the evaluation of the efficacy and safety of live or killed Lactobacillus sakei Probio65 on atopic dermatitis in childre
- Conditions
- Diseases of the skin and subcutaneous tissue
- Registration Number
- KCT0003928
- Lead Sponsor
- Probionic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 90
1) Those who agreed to participate in this test and presented a document, voluntarily signed by the subject, the parent, or legal representative
2) Those who aged 3 to 18 years
3) Those who have intermittent or persistent atopic dermatitis symptoms for more than 6 months
4) Those who have SCORAD scores between 20 and 50 (mild-moderate)
1) Those who have severe skin disease or systemic disease in addition to atopic dermatitis
2) Those who administered antibiotics, corticosteroids, antihistamines, or immuno-suppressants within 4 weeks of screening
3) Those who administered medicines, herbal medicine, or health functional foods to improve the symptom of atopic dermatitis within 4 weeks of screening
4) Those who received phototherapy within 4 weeks of screening
5) Those who have taken probiotics within 2 weeks of screening
6) Those who plan to participate in other tests during this clinical trial
7) Those who participated in other clinical trials within 4 weeks of the start of this clinical trial
8) Those who considered as inappropriate for this clinical trial by the judgment of the tester
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method